"Solubility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Descriptor ID |
D012995
|
MeSH Number(s) |
G02.805
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Solubility".
Below are MeSH descriptors whose meaning is more specific than "Solubility".
This graph shows the total number of publications written about "Solubility" by people in this website by year, and whether "Solubility" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 0 | 3 | 3 |
2008 | 0 | 1 | 1 |
2009 | 0 | 2 | 2 |
2010 | 0 | 3 | 3 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 2 | 40 | 42 |
2018 | 0 | 33 | 33 |
2019 | 0 | 15 | 15 |
2020 | 0 | 3 | 3 |
2021 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Solubility" by people in Profiles.
-
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings. Blood Coagul Fibrinolysis. 2021 Dec 01; 32(8):550-555.
-
Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study. Int Immunopharmacol. 2021 Oct; 99:108004.
-
Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation. Mol Pharm. 2021 08 02; 18(8):3108-3115.
-
Does COVID-19 alter the oxyhemoglobin dissociation curve? - An observational cohort study using a mixed-effect modelling. Clin Chem Lab Med. 2021 10 26; 59(11):e416-e419.
-
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. Eur J Med Chem. 2021 Oct 15; 222:113584.
-
Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation. Int J Pharm. 2021 May 15; 601:120600.
-
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations. Carbohydr Polym. 2021 Jul 15; 264:118011.
-
Role of Hydrogen Bonds in Formation of Co-amorphous Valsartan/Nicotinamide Compositions of High Solubility and Durability with Anti-hypertension and Anti-COVID-19 Potential. Mol Pharm. 2021 05 03; 18(5):1970-1984.
-
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell. 2021 04 29; 184(9):2384-2393.e12.
-
Expression of SARS-CoV-2 surface glycoprotein fragment 319-640 in E. coli, and its refolding and purification. Protein Expr Purif. 2021 07; 183:105861.